Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bioceres Crop Solutions (BIOX)
NASDAQ:BIOX
RESEARCH TOOLSreports
Earnings Data
Report Date
May 08, 2025TBA Not Confirmed
Period Ending
2025 (Q3)Consensus EPS Forecast
-0.13Last Year’s EPS
0.14Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 11, 2025
|% Change Since: -10.63%
|Next Earnings Date:May 08, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture with significant revenue and EBITDA declines due to challenges in Argentina. However, the company showed resilience with improved gross margins, stable market share, and successful geographic diversification. Strategic changes, including new partnerships and leadership appointments, are set to drive future growth and profitability.Company Guidance
In the Bioceres Crop Solutions fiscal second quarter 2025 earnings call, several key metrics and strategic changes were discussed. The company reported a 24% decline in revenues to $106 million, primarily due to challenging conditions in Argentina, which remains their primary market. Despite this, gross margins improved from 37% to 42%. Adjusted EBITDA for the quarter was $15.4 million, down from approximately $24 million in the year-ago quarter. The company also noted a strategic shift in their seed business, exiting breeding, seed production, and commercialization to focus on partnering with companies like GDM and Florimond Desprez. Additionally, Bioceres appointed Milen Marinov as the new Chief Commercial Officer, highlighting a move towards streamlining commercial operations. The company’s net debt increased to $238 million with a leverage ratio of 3.3. They managed to lower inventory levels by 18% year-over-year, aligning with a strategy to improve cash generation and capital allocation.Gross Margin Improvement
Despite a revenue decline, gross margin expanded from 37% to 42% due to a better product mix and reduced sales of lower-margin products.
Market Share Stability
The company maintained or slightly increased market share in key product families despite overall market contraction.
Geographic Diversification Success
Sales outside of Argentina grew, particularly in markets like Brazil, the US, Mexico, the Andean region, and Uruguay, supporting the company's diversification strategy.
Strategic Partnerships
New agreements with GDM for soybeans and Florimond Desprez for wheat to transition to a capital-light business model.
Appointment of New Chief Commercial Officer
Milen Marinov appointed as the new Chief Commercial Officer, expected to accelerate profitable growth and streamline commercial operations.
---
BIOX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
BIOX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 11, 2025 | $5.55 | $4.78 | -13.87% |
| Nov 12, 2024 | $6.48 | $6.66 | +2.78% |
| Sep 09, 2024 | $9.99 | $8.65 | -13.41% |
| May 13, 2024 | $12.35 | $12.00 | -2.83% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Bioceres Crop Solutions (BIOX) report earnings?
Bioceres Crop Solutions (BIOX) is schdueled to report earning on May 08, 2025, TBA Not Confirmed.
What is Bioceres Crop Solutions (BIOX) earnings time?
Bioceres Crop Solutions (BIOX) earnings time is at May 08, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is BIOX EPS forecast?
BIOX EPS forecast for the fiscal quarter 2025 (Q3) is -0.13.
---